These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 7297018

  • 1. Kinetics and renal handling of cefonicid.
    Pitkin D, Dubb J, Actor P, Alexander F, Ehrlich S, Familiar R, Stote R.
    Clin Pharmacol Ther; 1981 Nov; 30(5):587-93. PubMed ID: 7297018
    [Abstract] [Full Text] [Related]

  • 2. Azlocillin and cefonicid penetration into bone enhanced by probenecid.
    Summersgill JT, Harrod LG, Raff MJ.
    Antimicrob Agents Chemother; 1984 Sep; 26(3):292-4. PubMed ID: 6508259
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
    Barriere SL, Hatheway GJ, Gambertoglio JG, Lin ET, Conte JE.
    Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
    Neu HC.
    J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
    [Abstract] [Full Text] [Related]

  • 5. Cefonicid kinetics in subjects with normal and impaired renal function.
    Blair AD, Maxwell BM, Forland SC, Jacob L, Cutler RE.
    Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis.
    Barriere SL, Gambertoglio JG, Alexander DP, Stagg RJ, Conte JE.
    Rev Infect Dis; 1984 Jun; 6 Suppl 4():S809-15. PubMed ID: 6522922
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of cefonicid in uraemic patients.
    Fillastre JP, Fourtillan JB, Leroy A, Ramis N, Lefevre MA, Reumont G, Humbert G.
    J Antimicrob Chemother; 1986 Aug; 18(2):203-11. PubMed ID: 3759731
    [Abstract] [Full Text] [Related]

  • 8. An overview of pharmacokinetics.
    Cutler RE.
    Rev Infect Dis; 1984 Aug; 6 Suppl 4():S803-8. PubMed ID: 6522921
    [Abstract] [Full Text] [Related]

  • 9. Cross-over study of the pharmacokinetics of cefonicid administered intravenously or intramuscularly to healthy adult humans.
    Fourtillan JB, Leroy A, Lefebvre MA, Humbert G, Fillastre JP, Reumont G, Ramis N.
    Eur J Drug Metab Pharmacokinet; 1985 Aug; 10(3):225-30. PubMed ID: 3936717
    [Abstract] [Full Text] [Related]

  • 10. Ceftizoxime kinetics and renal handling.
    Dubb J, Actor P, Pitkin D, Alexander F, Familiar R, Ehrlich S, Stote R.
    Clin Pharmacol Ther; 1982 Apr; 31(4):516-21. PubMed ID: 6277546
    [Abstract] [Full Text] [Related]

  • 11. Multiple-dose pharmacokinetics of cefonicid in patients with impaired renal function.
    Phelps RT, Conte JE.
    Antimicrob Agents Chemother; 1986 May; 29(5):913-7. PubMed ID: 3729349
    [Abstract] [Full Text] [Related]

  • 12. In vitro experience with cefonicid.
    Actor P.
    Rev Infect Dis; 1984 May; 6 Suppl 4():S783-90. PubMed ID: 6522920
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of cefonicid in children.
    Furlanut M, D'Elia R, Riva E, Pasinelli F.
    Eur J Clin Pharmacol; 1989 May; 36(1):79-82. PubMed ID: 2917594
    [Abstract] [Full Text] [Related]

  • 14. Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans.
    Dudley MN, Shyu WC, Nightingale CH, Quintiliani R.
    Antimicrob Agents Chemother; 1986 Oct; 30(4):565-9. PubMed ID: 3789691
    [Abstract] [Full Text] [Related]

  • 15. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
    Tartaglione TA, Polk RE.
    Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304
    [Abstract] [Full Text] [Related]

  • 16. The pharmacology of cefamandole in patients with reduced renal function.
    Czerwinski AW, Pederson JA.
    Scand J Infect Dis Suppl; 1980 Mar; suppl 25():45-8. PubMed ID: 6937951
    [Abstract] [Full Text] [Related]

  • 17. Use of long half-life parenteral cephalosporins in ambulatory practice.
    Sauerwein M, Deamer RL, Prichard JG.
    J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
    [Abstract] [Full Text] [Related]

  • 18. Ceforanide kinetics.
    Estey EH, Weaver SS, LeBlanc BM, Brown N, Ho DH, Bodey GP.
    Clin Pharmacol Ther; 1981 Sep; 30(3):396-403. PubMed ID: 7273604
    [Abstract] [Full Text] [Related]

  • 19. Peritoneal transport of cefonicid.
    Morse GD, Lane T, Nairn DK, Deterding J, Curry J, Gal P.
    Antimicrob Agents Chemother; 1987 Feb; 31(2):292-4. PubMed ID: 3566253
    [Abstract] [Full Text] [Related]

  • 20. Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.
    Wallace RJ, Niefield SL, Waters S, Waters B, Awe RJ, Wiss K, Martin RR, Greenberg SB.
    Antimicrob Agents Chemother; 1982 Feb; 21(2):231-5. PubMed ID: 7041813
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.